Enhancing Outcomes in Opioid Use Disorder Treatment: An Economic Evaluation of Improving Medication Adherence for Buprenorphine Through Blister-Packaging.  Borrelli EP, Saad P, Barnes NE, Nelkin H, Dumitru D, Lucaci JD.  Subst Abuse Re...

Characteristics of patients who are initiated on long-acting buprenorphine (Buvidal®) in France: A retrospective cross-sectional study.  Deschenau A, Trojak B, Brousse G, Blecha L, Azuar J, Chappuy M, Touchon B, Kosim M, Rolland B.  Th...

Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.  Nosyk B, Min JE, Homayra F, et al.  JAMA. Published online October 17, 2024. doi:10.1001/jama.2024.16954 Abstract https://jamanetwork.com/journals/ja...

Listening Session: Use of High Dose Buprenorphine for the Treatment of Opioid Use Disorder  This report provides important insights into the effectiveness of high-dose buprenorphine for treating opioid use disorder, especially among individu...

Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts.  Chatterjee A, Stewart EA, Assoumou SA, et al.  JAMA Netw Open. 2024;7(10):e2437233. doi:10.1001/jamanetworkopen.2024.37233 https://jam...

Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization.  Axeen S, Pacula RL, Merlin JS, Gordon AJ, Stein BD.  JAMA Netw Open. 2024 Sep 3;7(9):e2435478. doi: 10.1001/jamanetworkopen.2024.35478. PMID: 39320889; P...